Cardioscan x9 | About Us
cardioscan, x9, cardioscanx9, cardioscan x9, heart, heart diagnosis, heartdiagnosis, heart diagnostic, magnetocardiography, mcg, device, mdical equipment, equipment, healthcare, uk, london, ukraine
13396
page-template,page-template-full_width,page-template-full_width-php,page,page-id-13396,qode-quick-links-1.0,ajax_fade,page_not_loaded,,vss_responsive_adv,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

About Us

WHO WE ARE

Our international team of developers (including doctors of medical sciences, professors, associate professors, research associates, cardiologists, doctors of functional diagnostics) began research and development of a modern method of non-invasive electrophysiology – magnetocardiography more than 20 years ago – in 1997.

 

Throughout the years, the team has worked on improving the diagnosis of heart disease using the method of magnetocardiography. The main obstacle faced by developers on the way to the widespread introduction of magnetocardiography into clinical practice was the impossibility of reducing interference, exceeding the useful signals by thousands of times, which led to the use of a very expensive screened camera. Our team produced 11 units of magnetocardiographs, which for today successfully operate and continue to perform their direct functions in the heart centers and clinics in Western & Eastern Europe and Asia.

 

In the course of their long operation, we have accumulated invaluable experience, examined many thousands of patients. The obtained experience allowed to design unique algorithms for recording MCG signals, as a result – a number of processes were optimized, applied technologies and procedures were improved. It allowed to abandon the shielded camera and develop a system applicable for operation in a normal clinic, in the presence of industrial city interference from various electronic equipment.

 

To date, all the developed innovative solutions in the field of magnetocardiography have formed the basis for our new model of magnetocardiograph – Сardioscan X9.

WHAT WE DO

R&D

Currently, our R&D department is actively developing the technology SQUID, applied in Cardioscan, in the following directions:

 

  • Human brain research (including artificial intelligence issues).
  • Fetal diagnosis of the heart of an unborn child.
  • Adaptability of organs during transplantation (possibility of rejection).
  • Diagnosis of liver diseases.
  • Portable devices – the possibility of using the method for B2C market entry.

Invest & Cooperate

We are open to cooperation with partners and investors. For communication please contact us at:

 

 

  • invest [at] cardioscan.one
  • tel. +44 (203) 8087813

Industrial production

At present, the main production is concentrated in Ukraine. To make a pre-order please follow the link below:

Distribute

We are in the process of forming a network of distributors. In order to apply please follow the link below:

Training of medical personnel

For effective work with the device, we will carry out a training of the staff of your institution.

Want to see more of our developments ? Visit our web-site !